Colorectal Neoplasia in the Setting of Inflammatory Bowel Disease

Surg Clin North Am. 2024 Jun;104(3):673-684. doi: 10.1016/j.suc.2023.12.006. Epub 2023 Dec 26.ABSTRACTInflammatory bowel disease (IBD) is associated with an increased risk of colorectal cancer (colorectal adenocarcinoma [CRC]) compared with the general population. IBD-related CRC is related to poorer outcomes than non-IBD-related CRC, and it accounts for 10% to 15% of death in patients with IBD. As such, screening guidelines have been made specific to this population recommending shorter intervals of endoscopic screening to detect dysplasia and CRC relative to the general population. Advances in endoscopic technology allow for improved visualization of dysplasia, which has led to widespread adoption of dye-spray chromoendoscopy with targeted biopsy.PMID:38677829 | DOI:10.1016/j.suc.2023.12.006
Source: Clinical Colorectal Cancer - Category: Cancer & Oncology Authors: Source Type: research